A COMPARATIVE CLINICAL STUDY ON THE EFFECT OF GUDUCHI-BHADRAMUSTADI YOGA ADMINISTERED ORALLY AND AS BASTI IN THE MANAGEMENT OF STHAULYA W.S.R. TO OBESITY
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 20
- Locations
- 1
- Primary Endpoint
- Weight reduces
Study Overview
Brief Summary
This study is a random open trial which isdivided into two groups.
In one group, Guduchi-Bhadramustadi Yogabasti was given for 16 days (Basti in scheduleof 1 anuvasan 3 niruha1 anuvasan3 niruha1 anuvasan3 niruha1 anuvasan2 niruha1 anuvasan=16 Basti) with follow up of 1 month.
In second group, Guduchi-Bhadramustadi YogaGhanavati was given 7gm/day into 3 divided doses before meal with luke warmwater for 1 month & 15 days of follow up.
Effect of therapy will beassessed by before and after values of routinehematological, urine investigation, lipid profile, weight, body girthmeasurement.
Study Design
- Study Type
- Interventional
- Allocation
- Random Number Table
- Masking
- Open Label
Eligibility Criteria
- Ages
- 18.00 Year(s) to 60.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Patient having classical sign and symptoms of Sthaulya like Chala Udara Stana Sphika Javoparadha Kruchravyavaya Durbalata Atikshudha Atitrishna etc Patient having sign and symptoms of Obesity like Large body frame Having extra fat around the waist Difficulty in doing daily activities Lethargy Breathlessness Increased weight Snoring Heavy sweating Difficulty while sleeping Etc BMI more than 25 and less than 40 BMI Prime more than 1 Waist hip ratio Male: more than 0.95 Female more than 0.80.
Exclusion Criteria
- •Patients having age less than 18 years & above 60 years.
- •Patients having serious cardiac, renal and hepatic diseases etc.
- •Patients having major illness like Diabetes Mellitus which is poorly controlled.
- •Patients having history of untreated thyroid disorders and uncontrolled Hypertension and other endocrine diseases.
- •Obesity due to drugs e.g. Anticonvulsant, antipsychotics, Beta-blockers, Corticosteroid.
- •Pregnant females & lactating women.
- •BMI>40 will be excluded.
- •Waist-Hip ratio: Man: 0.95 or below Female: 0.80 or below.
Outcomes
Primary Outcomes
Weight reduces
Time Frame: 1.5 months
In basti group more than ghanavati group
Time Frame: 1.5 months
Secondary Outcomes
- In basti group weight reduces more than ghanavati group(45 days)
